cyrus vincent
May 5, 2016
Featured

SpinalCyte, LLC Receives New United States Patent for Spinal Disc Tissue Engineering

SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the issuance of U.S. Patent No. 9,320,776, "Methods And Compositions For Repair Of Cartilage Using An In Vivo Bioreactor."  The technology described in the patent involves a device which is a resorbable and biodegradable structure that can be permeable to oxygen but hermetic to fluids.  Also claimed in the patent is the device having outer biodegradable membrane that encompasses nutrients and/or growth factors.

http://www.prnewswire.com/news-releases/spinalcyte-llc-receives-new-united-states-patent-for-spinal-disc-tissue-engineering-300262156.html